A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
IsraelRecruitingPHASE1
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Conditions
Malignant Neoplasm
Locations
- Rutgers Cancer Institute of New Jersey ( Site 0052), New Brunswick, New Jersey, United States
- NEXT Oncology ( Site 0051), Irving, Texas, United States
- NEXT Virginia ( Site 0054), Fairfax, Virginia, United States
- Blacktown Hospital ( Site 0455), Sydney, New South Wales, Australia
- One Clinical Research ( Site 0454), Nedlands, Western Australia, Australia
- Pontificia Universidad Catolica de Chile-CICUC ( Site 0103), Santiago, Region M. de Santiago, Chile
- Bradfordhill ( Site 0102), Santiago, Region M. de Santiago, Chile
- Rambam Health Care Campus ( Site 0252), Haifa, Israel
- Rabin Medical Center ( Site 0253), Petah Tikva, Israel
- Sheba Medical Center ( Site 0251), Ramat Gan, Israel
- Seoul National University Hospital ( Site 0501), Seoul, South Korea
- Asan Medical Center ( Site 0502), Seoul, South Korea
- Hospital General Universitari Vall d Hebron ( Site 0360), Barcelona, Spain
- Hospital Clinic de Barcelona ( Site 0362), Barcelona, Spain
- Hospital Universitario Fundacion Jimenez Diaz ( Site 0361), Madrid, Spain